Clinical Trial Update: High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial is evaluating high-dose ascorbate in combination with azacitidine and venetoclax for Acute Myeloid Leukemia. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Ascorbic acid (high-dose) (ascorbic acid)
• Venetoclax (venetoclax)

Snippet

Sponsor: Kittika Poonsombudlert | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING